October 2020 Price Paid Data

News story

HM Land Registry Price Paid Data tracks land and property sales in England and Wales submitted to us for registration.

Image credit: Wei Hung/Shutterstock.com

This release contains updates to the releases we’ve made this year, as well as introducing the first release of data for October 2020.

As we will be adding to the October data in future releases, we would not recommend using it in isolation as an indication of market or HM Land Registry activity. However, when the full dataset is viewed alongside the data we’ve previously published, it adds to the overall picture of market activity.

Access the full dataset

There is a time difference between the sale of a property and its registration at HM Land Registry.

In the dataset you can find the date of sale for each property, its full address and sale price, its category (residential or commercial) and type (detached, semi-detached, terraced, flat or maisonette and other), whether or not it is new build and whether it is freehold or leasehold.

Published 27 November 2020




Government asks regulator to approve supply of Oxford/AstraZeneca vaccine

  • Government requests medicines regulator evaluate whether supply of Oxford/AstraZeneca vaccine can be authorised
  • Vaccine must first meet the UK’s high standards of safety, efficacy and quality
  • Move would mean potentially faster access to the vaccine for UK patients, if approved

The government has formally requested the UK’s independent medicines regulator assess the suitability of Oxford/AstraZeneca’s COVID-19 vaccine for temporary supply, as soon as the company submits the necessary safety, quality and efficacy data.

The move marks a significant first step in getting the vaccine approved for deployment, should it meet the regulator’s requirements.

The UK will be one of the first countries in the world to receive the vaccine, if authorised, with AstraZeneca expecting to have up to 4 million doses ready for the UK by the end of the year and 40 million by the end of March 2021.

The UK is the first country in the world to sign an agreement with Oxford University/AstraZeneca, securing access to 100 million doses of the vaccine

Earlier this week, the University of Oxford and AstraZeneca published their interim efficacy results, which indicated the vaccine was at least 70% effective in protecting individuals from COVID-19.

This rose to 90% effective when administered as half a dose, followed by a full dose – rather than 2 full doses.

Health and Social Care Secretary Matt Hancock said:

We are working tirelessly to be in the best possible position to deploy a vaccine as soon as one is approved by the independent regulator, the MHRA.

We have formally asked the regulator to assess the Oxford/AstraZeneca vaccine, to understand the data and determine whether it meets rigorous safety standards. This letter is an important step towards deploying a vaccine as quickly as safely possible.

In a letter sent by the Department of Health and Social Care to the Medicines and Healthcare products Regulatory Agency (MHRA), the government has asked the regulator to assess the vaccine for authorisation under Regulation 174 of the Human Medicines Regulations, which enables the temporary supply of medicines to be authorised in response to a public health need.

The MHRA has already started a rolling review to determine whether the Oxford/AstraZeneca vaccine meets its strict standards of safety, efficacy and quality.

Once the MHRA receives the full data from the company, its renowned team of scientists and clinicians stand ready to progress its assessment of the vaccine.

Until the end of December, and as part of the transition period, vaccines must be authorised via the European Medicines Agency and that authorisation will automatically be valid in the UK.

However, if a suitable COVID-19 vaccine candidate, with strong supporting evidence of safety, quality and effectiveness from clinical trials becomes available before the end of the transition period, EU legislation which we have implemented – Regulation 174 – allows the MHRA to temporarily authorise the supply of a medicine or vaccine, based on public health need.

The letter, signed by Deputy Chief Medical Officer for England Professor Jonathan Van-Tam and Director for COVID-19 Vaccine Deployment Antonia Williams, requests the MHRA’s Chief Executive Dr June Raine for the MHRA to evaluate whether the vaccine can be authorised under this regulation.

The government has already formally asked the MHRA to assess the Pfizer/BioNTech vaccine for its suitability for authorisation under Regulation 174.

Until a vaccine is approved, the public must continue to take necessary actions to keep themselves and their loved ones safe including by following the ‘Hands. Face. Space’ guidance and other public health advice.

Medical countermeasures such as effective therapeutics and vaccines could eventually make COVID-19 a more manageable disease, reducing its impact on society and the NHS so we can begin to get back to normal.

The MHRA is the UK’s independent regulator, globally recognised for requiring the highest standards for quality, safety and effectiveness.

After the transition period ends in January 2021, the MHRA will have new powers to approve medicines, including vaccines, and will have greater flexibility to do this in a shorter time, while maintaining the highest standards of safety, quality and effectiveness.

The Joint Committee on Vaccination and Immunisation (JCVI) are the independent experts who advise the government on which vaccines the UK should use and provide advice on who should be offered the vaccination first. The committee’s interim advice is that a COVID-19 vaccine should first be given to care home residents and staff, followed by people over 80 and health and social workers, then to the rest of the population in order of age and risk.

Vaccination will be managed by the health services in each nation: NHS England and NHS Improvement, NHS Wales, NHS Scotland, and Health and Social Care Northern Ireland.

The government has previously announced funding for the Oxford University/AstraZeneca vaccine including:

  • £2.6 million announced on 23 March 2020
  • £20 million announced on 21 April 2020
  • £65.5 million announced on 17 May 2020

Through the government’s Vaccines Taskforce, the UK has secured early access to 355 million doses of 7 of the most promising vaccine candidates, including:

  • Pfizer/BioNTech for 40 million doses
  • Oxford/AstraZeneca for 100 million doses
  • Moderna for 5 million doses
  • GlaxoSmithKline and Sanofi Pasteur for 60 million doses
  • Novavax for 60 million doses
  • Janssen for 30 million doses
  • Valneva for 60 million doses



Oxford/AstraZeneca COVID-19 vaccine: MHRA statement confirming letter received

News story

The safety of the public will always come first.

“We are pleased to have received the letter from the Department of Health and Social Care requesting review of the Oxford/AstraZeneca COVID-19 vaccine candidate.

“Our job will be to rigorously assess the latest data and evidence to be submitted of the vaccine’s safety, quality and effectiveness.

“We will seek advice from the Government’s independent advisory body, the Commission on Human Medicines. The Commission will critically assess the data too before advising the UK government on the safety, quality and effectiveness of any potential vaccine.”

“The safety of the public will always come first. Our role is to work to the highest standards and safety is our watch word.”

Published 27 November 2020




Nightclub owners banned for failing to submit accounts and pay tax

Paula Kelly (55) and Paul Anthony Kelly (58), from Thornton Cleveleys in Lancashire, will start their 7-year directorship disqualifications on 25 November 2020.

Husband and wife are both banned from acting as directors of a company or directly or indirectly becoming involved, without the permission of the court, in the promotion, formation or management of a company.

Flexitell Limited was incorporated in March 2016 and Paul and Paula Kelly were appointed as directors. Husband and wife managed several nightclubs and pubs in Blackpool under the trading name Ma Kelly’s.

The company, however, entered into administration in May 2017 and Flexitell was referred to the Insolvency Service for further enquiries.

Investigators found that Paul and Paula Kelly had not maintained or preserved accounting records throughout the life of the company. This has meant the nightclub owners could not explain their claimed £1.1 million turnover, £195,000-worth of tax owed, and the outstanding balances on their directors’ loans.

On 9 November 2020, the Secretary of State accepted disqualification undertakings from both Paul and Paula Kelly after husband and wife did not dispute they had failed to ensure Flexitell maintained or preserved adequate accounting records explaining an estimated company turnover in excess of £1 million and a £194,000 debt owed to the tax authorities.

Mike Smith, Chief Investigator at the Insolvency Service, said:

Failing to keep accounting records up to date is a serious obligation for any business director. The Kellys did not take their responsibilities seriously and at no point did they engage with our investigation.

These bans should serve as a warning that if company directors do not keep good company records, they run the risk of facing disqualification from their business for a significant period.

Paula Kelly is from Thornton Cleveleys and her date of birth is December 1965.

Paul Kelly is from Thornton Cleveleys and his date of birth is February 1962.

Flexitell Systems Limited (Company number 10057208)

Disqualification undertakings are the administrative equivalent of a disqualification order but do not involve court proceedings.

Persons subject to a disqualification order are bound by a range of other restrictions.

Further information about the work of the Insolvency Service, and how to complain about financial misconduct, is available.

You can also follow the Insolvency Service on:




Thousands of women and girls to benefit from £15m Tampon Tax Fund

Charities supporting disadvantaged women and girls through the coronavirus pandemic and recovery are to receive £15 million from the latest round of the Tampon Tax Fund.

Projects that help victims of domestic abuse, work with eating disorder sufferers, and provide mentoring for disadvantaged young women, are among those to receive grants of more than £1 million each over the next two years.

The money will also be used to make grants to smaller organisations so they can deploy services that support vulnerable women and girls.

Minister for Civil Society, Baroness Barran, said:

Vulnerable women and girls need our support more than ever in this difficult year, and these grants will help keep vital services going.

From supporting victims of domestic abuse, to those suffering from mental health problems, this funding will help to directly tackle some of the most serious issues facing women and girls today.

This year’s recipients can also use part of their grant funding to improve the sustainability of their organisations, helping them continue their vital work into the future.

The deadline for applications was extended this year in light of the coronavirus outbreak, to ensure as many front line charities as possible were able to apply.

The 12 projects receiving funding from this round of the Tampon Tax are:

Women in Prison (£1,000,000): The Creating Community Connections Project links women in prison with a network of local women’s centres, to offer holistic support to meet their needs, address root causes of offending, improve outcomes on release and intercept cycles of trauma, disadvantage and abuse.

Ovarian Cancer Action (£1,259,788): The funding will go towards a project to spearhead equal access to clinical excellence for all women with ovarian cancer regardless of where they live, their age or ethnicity.

Solace Women’s Aid (£1,614,288): The Labyrinth Project will help ensure all women have access to the support they need in the spaces most appropriate for them, joining up expertise across legal, economic, social and community spheres.

Rosa Fund (£1,906,855): Funding will benefit 27,000 women and girls through onward grants to 140 organisations of all sizes, helping them to navigate the pressures of the pandemic.

SafeLives (£1,488,534): The Your Best Friend project will empower 10,000+ young women with knowledge and confidence to act before someone harms or is harmed, to keep themselves and others safe.

Comic Relief (£1,282,173): Funding will be used for onward grants of between £40,000 and £250,000 to organisations led by BAME women for BAME women, to address violence against women and girls in England.

The Medaille Trust (£1,000,714): The Moving On Project focuses on meeting the long-term needs of women affected by trafficking and modern slavery.

Standing Together Against Domestic Abuse (£1,203,610): Funding the national roll out of Specialist Domestic Abuse Courts to improve the criminal justice response to domestic violence.

London Youth (£1,000,000): The programme will support BAME girls aged 10-14 and a cohort of 30+ youth workers, funding activities to promote mental health and wellbeing.

YMCA England and Wales (£1,000,861.00): Y’s Girls Mentoring will identify young people at risk of developing mild to moderate mental health issues and match them with a trained community-based volunteer mentor.

Beat (£1,074,032): The Keystone project aims to provide better health outcomes for girls and young women suffering from eating disorders through support for their carers.

Rape Crisis Scotland (£1,019,144.00): The Access to Change project aims to build the capacity of Rape Crisis services across Scotland to meet the needs of survivors of all forms of sexual violence, especially those who face additional barriers to support.

The Tampon Tax Fund uses the funds generated from the VAT on women’s sanitary products.

While the UK was a member of the European Union, VAT on these products could not fall below 5 per cent. The Chancellor announced in March this year that the tax will end in January 2021, at the end of the transition period following the UK’s exit from the EU.

Today’s announcement builds on the Government’s unprecedented £750 million package of support which is ensuring that tens of thousands of frontline charities can meet increased demand as a result of the coronavirus pandemic, and continue their vital work supporting those in need. This funding includes:

  • The £200 million Coronavirus Community Support Fund for small and medium-sized charities working on the front line across England.
  • £360 million via government departments, including £200 million to hospices across England, and £79 million to charities that support vulnerable children and people who have suffered from domestic abuse, sexual abuse and modern slavery;
  • £37 million to the BBC’s Big Night In appeal, which has matched the generosity of the public in raising funds for Children In Need, Comic Relief and the National Emergencies Trust;
  • £85 million through DCMS’ Community Match Challenge, which has doubled the money raised by recipients including Greggs Foundation, the Steve Morgan Foundation, Comic Relief and Global Radio’s ‘Make Some Noise’ campaign to unlock more than £160 million for good causes;
  • £60 million to the Devolved Administrations to support charities in Scotland, Wales and Northern Ireland;
  • £5 million to the Voluntary and Community Sector Emergencies Partnership to support volunteers in local areas.

It comes on top of the £150 million released from dormant accounts to help social enterprises get affordable credit to people who are financially vulnerable and support charities tackling youth unemployment.

With the wider Government financial support schemes in place, charities will continue to benefit from an unprecedented multi-billion-pound package of support.

ENDS

Notes to Editors

Additional quotes:

Denise Hatton, Chief Executive of YMCA England & Wales, said:

We are hugely grateful to have been selected as one of the recipients of the Tampon Tax Fund, the vital means from which will enable us to deliver our Y’s Girls mentoring programme.

We know that mental health issues among this age range are rising dramatically, and on top of that consistent and damaging cuts to youth services have left many young people isolated and without essential support.

Funding from the Tampon Tax Fund provides a much-needed bridge within our youth work, helping to reach young women and girls in their time of need.

Andrew Radford, Chief Executive of Beat, said:

We are extremely grateful for this new funding, which will help to support girls and young women suffering from eating disorders through training and support for families and carers.

We hope that our new work, made possible through the Tampon Tax Fund, will help to transform lives and allow as many people as possible to make full and sustained recoveries.

Cary Wakefield, Chief Executive Officer of Ovarian Cancer Action, said:

We are hugely grateful to be one of this amazing group of women’s charities to receive a grant from the Tampon Tax Fund.

The funding will enable us to address the very real health inequalities that exist and ensure all women with ovarian cancer receive the best standard of care, regardless of their age, ethnicity or location. This could significantly improve survival rates in the UK and we can’t wait to get started.

Rebecca Gill, Executive Director of Rosa, said:

Rosa UK and Smallwood Trust are delighted to have received money from the Tampon Tax fund. We are looking forward to distributing this funding to where it is most needed, enabling women’s organisations across the UK to support women and girls to overcome the complex and long-lasting challenges brought about by the Covid-19 pandemic. We know women’s organisations are in desperate need of funding to enable them to do this vital work.

Gerry Smith, Chief Executive Officer of the Medaille Trust, said:

We are so grateful to the Tampon Tax Fund for this phenomenal level of support. The £1million award will enable us and our partner, The Snowdrop Project, to deliver long-term support to vulnerable women affected by human trafficking and modern slavery.

The Moving On Project will give women the vital support they need to move forward with their lives, while reducing their vulnerability to abuse, violence and exploitation in the future.

Kate Paradine, Chief Executive of Women in Prison, said:

This funding will help hundreds of women in prisons across the country to connect with vital support services in their communities, including the network of specialist women’s centres.

Fiona Dwyer, Chief Executive Officer of Solace Women’s Aid, said:

This important fund will help us to create lasting change to the lives of the most marginalised women across three nations and the women’s groups and organisations that support them.

Only The Tampon Tax fund could meet the scale of our ambitions and we thank the Department for Digital, Culture, Media and Sport for their insight and confidence in enabling Solace and our incredible partners to create lasting change to the lives of over 20,000 women across three nations.

Pauline Daniyan, Director of Programmes at London Youth, said:

Young people today face a daunting reality. The pandemic could not have come at a worse time for them – just as they grow and develop their potential.

It is a tremendous opportunity to support youth clubs to be mental health hubs and extend this vital support for young women outside of schools and into the youth centres that make them feel welcome, supported and safe.

Suzanne Jacob, Chief Executive Officer of SafeLives, said:

Young women who are worried about their relationships turn to their friends and online, not to traditional services. Your Best Friend is a future-facing project from a creative partnership of charities and digital experts.

Working hand in hand, we’ll empower girls and young women to place the advice and reassurance they urgently need where young women already are – keeping them and their friends safe.

Ruth Davison, Chief Executive Officer of Comic Relief, said:

The alarming rise in domestic violence throughout the pandemic means that vital services are needed now more than ever.

With the generous support from the Tampon Tax we will work with frontline Black, Asian and minority led organisations that help women at risk of violence and abuse across England, especially those who find it harder to access mainstream services.

Sandie Barton, Director of Operations at Rape Crisis Scotland, said:

Seeking support after sexual violence is never an easy thing to do which is why it is so important that when someone is able to take that step, Rape Crisis Centres are resourced and able to be there at the point of need.

This welcome funding will make a real difference to survivors in Scotland not just by increasing capacity at a local level, but in carving paths to make sure that those who are too often locked out of support have a clear route in.